New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
10:00 EDTSLAB, PFPT, NMBL, NXPI, INVN, GCO, CSTE, BCRX, ASHOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Ashland (ASH) initiated with a Buy at UBS... BioCryst (BCRX) initiated with an Overweight at JPMorgan... Caesarstone (CSTE) initiated with a Buy at UBS... Genesco (GCO) initiated with a Hold at Jefferies... InvenSense (INVN) initiated with a Buy at Canaccord... NXP Semiconductors (NXPI) initiated with a Buy at Canaccord... Nimble Storage (NMBL) initiated with an Outperform at Wells Fargo... Proofpoint (PFPT) initiated with an Outperform at Wells Fargo... Silicon Laboratories (SLAB) initiated with a Buy at Canaccord.
News For ASH;BCRX;CSTE;GCO;INVN;NXPI;NMBL;PFPT;SLAB From The Last 14 Days
Check below for free stories on ASH;BCRX;CSTE;GCO;INVN;NXPI;NMBL;PFPT;SLAB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 12, 2014
16:44 EDTNXPIMarket ends week lower as investors fret over Fed statement
Subscribe for More Information
September 11, 2014
08:38 EDTNXPIDemand for NXP Semiconductors NFC products could rise, says Sterne Agee
After Apple (AAPL) launched a mobile payments product, Sterne Agee thinks that NXP Semiconductors (NXPI) was one of the clear winners of the Apple product launches. The firm thinks that broader adoption of NXP's NFC chips and secure element could cause the company's stock to rise significantly. The firm keeps an $82 price target and Buy rating on the shares.
07:40 EDTASHAshland management to meet with Deutsche Bank
Meetings to be held in Delaware/Maryland on September 11 hosted by Deutsche Bank.
September 10, 2014
08:28 EDTNXPINXP Semiconductors to benefit from Apple devices, says Pacific Crest
Subscribe for More Information
07:51 EDTNXPINXP Semiconductors a key beneficiary of Apple's new products, says ISI Group
Subscribe for More Information
07:47 EDTASHAshland management to meet with Deutsche Bank
Subscribe for More Information
September 9, 2014
13:50 EDTNXPINXP Semiconductors turns positive after Apple confirms NFC in new iPhone
Shares of On Track Innovations (OTIV) are still negative but moving higher.
13:47 EDTNXPINXP Semiconductors off lows as Apple unveils 'Apple Pay' service
Subscribe for More Information
13:37 EDTINVNInvenSense rises 2.5% during Apple iPhone launch event
InvenSense (INVN) provides intelligent motion processing solutions. Apple (AAPL) discussed the motion sensing capabilities of its new phone during the launch presentation.
10:47 EDTNXPILeak points to no NFC or sapphire cover for smaller iPhone 6, BGR says
Subscribe for More Information
06:18 EDTNXPINXP Semiconductors volatility low into Apple event
Subscribe for More Information
September 8, 2014
08:45 EDTNMBLNimble Storage, Arista, CommVault recommnded on M&A at Pacific Crest
Subscribe for More Information
08:09 EDTNMBLNimble Storage initiated with an Outperform at FBN Securities
Subscribe for More Information
07:01 EDTPFPTProofpoint remains a favorite play in security at RBC Capital
RBC Capital believes the security demand environment is accelerating due to recent security breaches and Proofpoint's products continue to resonate well. The analyst said cross selling opportunities are sizable while productive gains are driving billings growth. The firm said Proofpoint is a favorite name in security and raised its price target ot $46 from $43. Shares are Outperform rated.
September 7, 2014
12:42 EDTBCRXBioCryst announces RAPIVAB trial results for the treatment of influenza
Subscribe for More Information
September 5, 2014
19:58 EDTGCOGenesco management to meet with SunTrust
Subscribe for More Information
10:57 EDTBCRXBioCryst falls after WHO posts document on potential Ebola therapies
Shares of BioCryst Pharmaceuticals (BCRX) are sliding in early trading after the World Health Organization posted documents ahead of a meeting it is holding to discuss the recent Ebola outbreak and potential strategies to combat the disease. WHAT'S NEW: This week, on September 4-5, WHO is bringing together technical experts from the groups developing Ebola interventions along with people working to overcome Ebola virus disease, the group stated on its website. WHAT'S NOTABLE: In a background document on potential Ebola therapies and vaccines, WHO wrote regarding the availability and feasibility of BCX4430 from Biocryst that the drug "needs animal treatment and protection data for EVD before it can be considered. No material is currently available for field use." PRICE ACTION: Shares of BioCryst are down 50c, or 3.76%, to $12.28. Reference Link
09:17 EDTINVNInvenSense recent price action creates attractive entry point, says RW Baird
Subscribe for More Information
September 4, 2014
16:35 EDTPFPTFinjan provides litigation update, Proofpoint motion to stay denied
Finjan Holdings provides an update on the case Finjan (FNJN) v. Proofpoint (PFPT) et al., Case No. 5:13-cv-05808-BLF. The Honorable Beth Labson Freeman denied Proofpoint's Motion to Stay the Case pending the completion of the U.S. Patent and Trademark Office's reexamination of claims in two of eight patents-in-suit representing only 10% of the Claims in question. The Court declined to issue a Stay by concluding it "…would unnecessarily delay this litigation and unduly prejudice the interests of [Finjan]." The current matter with Proofpoint is expected to continue with the Court's previously determined calendar including a Markman hearing, which is scheduled for May 8, 2015 and trial, which is set to begin January 11, 2016.According to Julie Mar-Spinola, VP, Legal Operations of Finjan, "The Court's denial of Proofpoint's Motion to Stay clears the way for the parties to prove their respective claims against the other expeditiously and on the merits, which we believe is fair for all parties concerned."
11:59 EDTNXPIApple to feature NFC in iWatch as well as iPhone, WSJ says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use